142, there clearly is mutual benefit...thanks for sharing.
I had previously research the "history" lesson, and wrote off the top of my head earlier. Here's the more complete details:
The first “PC Awareness Day” was organized in 1990 by a pharmaceutical company to “celebrate” the release of the very first anti-androgen drug, fultimide, which was for late-stage PC cases. In a ploy of marketing genius, the pharmaceutical’s newly organized “Awareness Day” included promotion of the new PSA test because it would help to identify more patients and therefore maximize sales of the new drug (a.k.a. trolling for customers). This was, of course, roughly co-incident with Dr Patrick Walsh’s breakthrough “nerve-sparing” surgery technique which also helped to facilitate a "bloom" in the market and starting by the mid-90s “mass PSA screening” began aggressively pushing upstream to younger and younger patients, and finding more and more incidental varieties of PC.
By the 2000s, 80% of PC diagnosis had shifted to being “organ confined,” yet there was absolutely no stigma attached to urologists rushing patients into life-altering aggressive treatment without regard to high-risk, intermediate-risk, or low-risk. In the early 2000s though, medical thought-leaders began speaking loudly in their professional societies against mass screenings and overtreatment. But appealing to the clinician’s to do the right thing (stop overtreating) was ineffective, and it took the landmark USPSTF action in 2012 to finally squash (nearly) the practice of sending junior hematologists out from local hospitals to troll for customers at mass screenings at the mall, at work, at the race track, at the YMCA, in a mobile van, etc. It is important that we understand history so that we don't repeat it. but that USPSTF decision is a piece of PC history that we should all understand how it protects our brothers as a whole.
Post Edited (Blackjack) : 11/15/2018 1:42:42 PM (GMT-7)